Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | -0.64% | +3.33% | -78.47% |
May. 16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
May. 16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 61.03M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.85% |
1 day | -0.64% | ||
1 week | +3.33% | ||
Current month | -1.90% | ||
1 month | -8.82% | ||
3 months | -86.58% | ||
6 months | -74.21% | ||
Current year | -78.47% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 1.55 | -0.64% | 46,062 |
24-06-04 | 1.56 | -4.88% | 18,197 |
24-06-03 | 1.64 | +3.80% | 22,927 |
24-05-31 | 1.58 | +9.72% | 93,334 |
24-05-30 | 1.44 | -4.00% | 105,029 |
Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.47% | 60.5M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- AEON Stock